Amide Technologies is a platform technology company leveraging heat, flow, and machine learning to enable fast, reliable synthesis of complex peptides.
We expand what is possible, bridging the gap between traditional solid phase peptide synthesis and biological expression. We can synthesize linear peptides up to 120 Amino Acids, larger peptides and proteins with NCL, mirror image peptides, macrocycles, and branched structures.
Sinopep (688076.SH) is a trusted CDMO specializing in end-to-end CMC development and cGMP manufacturing of peptide, oligonucleotide, and small molecule APIs. With nearly 15 years of experience, we support global pharmaceutical and biotech partners from early-phase development through commercialization. Our services include process and analytical method development, validation, stability studies, and regulatory support for global filings (IND/NDA). Since 2009, Sinopep has passed four U.S. FDA inspections and operates in strict compliance with FDA and ICH guidelines. We are also the world’s leading exporter by volume of Semaglutide, Tirzepatide, and Liraglutide APIs—trusted by top pharmaceutical companies for commercial supply.
With one of the world’s most flexible production capacities—ranging from milligram-scale discovery to 200+ kg commercial batches—we help accelerate drug development by prioritizing early-phase CMC readiness and delivering Phase 3–ready packages as early as Phase 2b, supporting fast-track and breakthrough therapy programs.
Unified Separation Technologies (UST), based in Wilmington, DE, specializes in advanced chromatography solutions for high-performance purification. Our Bonnasil silica features high-purity spherical particles, a narrow pore size distribution, and proprietary asymmetric bonding—designed for efficient and selective impurity removal.
Our media is optimized for peptide and nucleic acid drug purification applications. Backed by over 30 years of expertise in silica chemistry and separation science, our founding team is committed to delivering innovative solutions that elevate purification processes in biomanufacturing.
Established in 1984, Neuland Labs is a global Contract Development and Manufacturing Organization (CDMO) offering comprehensive services for the development of customized new chemical entities (NCEs) small molecules, and peptides. Neuland’s custom peptide synthesis services include production of peptides from milligrams to multi-kilogram scale by standard sequential chemical peptide synthesis and segment condensation strategies. Neuland Labs specializes in synthesising both linear and cyclic peptides. The company has a dedicated state-of-the-art facility for custom peptide synthesis and adheres to green chemistry principles. With capabilities spanning from small-scale clinical trial quantities to full-scale commercial supplies, Neuland has successfully developed and manufactured complex peptides from 6AA to 41AA using SPPS, LPPS and hybrid technologies for clinical trials on 10s of grams to 10s of Kgs.
For more information on our services, visit https://www.neulandlabs.com/en/cdmo-services/peptides
Snapdragon Chemistry, a Cambrex company, specializes in active pharmaceutical ingredient (API) batch and continuous flow process. Snapdragon also has extensive experience in the development and cGMP manufacture of peptides. Data rich experimentation and advanced PAT enabled by our proprietary LabOS enable Snapdragon to efficiently determine the design space and optimal conditions for complex synthetic manufacture. We are able to leverage technologies such as solid phase and liquid phase synthesis, tangential flow filtration, nano filtration, ion exchange chromatography, wiped film evaporation to enable robust and reproducible cGMP manufacture of complex synthetics.
UI Pharmaceuticals is the longest running and most experienced university-affiliated FDA-registered pharmaceutical drug product manufacturing facility in the United States. We offer pharmaceutical drug product development, manufacturing, and testing services for sterile solutions, lyophilized products, tablets, capsules, and non-sterile powder, semisolid, and liquid products.
UI Pharmaceuticals’ senior staff has an average of over 25 years of experience at UI Pharmaceuticals. We have been a stable, reliable source of contract pharmaceutical manufacturing and testing in compliance with cGMPs since 1974.
YMC is a premier separations technology company that designs and manufactures products, and offers services associated with the purification of pharmaceutical and biopharmaceutical compounds. As a full-spectrum liquid chromatography and downstream purification provider, the company offers resins; prepacked capillary, analytical, and preparative columns; glass columns; DAC/DAD columns; and Contichrom® CUBE and TWIN LPLC and HPLC multi-column systems. A strong history of custom work has allowed YMC to enhance its technology and develop a diverse platform of products and services that align with clients’ specific requirements. This allows customers to select the YMC products and optimized methodologies that result in maximum process efficiency. In addition, YMC’s highly trained and knowledgeable technical staff supports each customers’ individualized needs for process optimizations.
For more information about YMC American, please visit our website at www.ymcamerica.com
BioDuro, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for 29 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US with operations in China, totaling 2,000+ scientists and 7 global sites across 6 cities.
Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, people-focused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate our development timeline.
For more information about BioDuro, please visit our website at www.bioduro.com
Founded in the late 1990s Intavis Peptide Services (IPS) has around 30 years of experience in peptide synthesis. As a part of the Intavis Instruments corporation Intavis Peptide Services initially synthesized peptides to validate analytical instruments. However, when the scientific and medical community realized the great potential of peptide drugs, such as Insulin and many more peptide-based blockbusters, Intavis expanded their custom peptide synthesis division. Until today, IPS has contributed to many research projects and partnered with global companies. IPS provides comprehensive service around customized peptide synthesis – from project inception to final peptide-based medicinal product. Indeed, our products are also used in vaccine development and personalized cancer therapy.
Intavis Peptide Services blends hands-on experience, scientific knowledge and dedicated employees to a unique service offering for their customers. Our seasoned leadership team has decades of experience in the biotech and life science space and our partners support us with their expertise and network. Our reliability, effectiveness and customer focus earned us an excellent reputation in the custom peptide synthesis space. https://intavispeptides.com/en/
Asymchem is a leading global CDMO known for its integrated offerings throughout the entire drug development lifecycle. From early-stage research to commercialization, we provide a tailored suite of services that cater to the specific needs of each project.
We are committed to embracing cutting-edge technologies that not only enhance efficiency and safety but also prioritize sustainability in the development and manufacturing process. This translates to smarter, greener, and more cost-effective solutions for our clients, ultimately speeding up the delivery of life-saving medications to patients. https://asymchem.com/
Asymchem Inc.
location_on600 Airport Blvd, Suite 1000, Morrisville, NC 27560 USA
local_phone+1-919-897-8807